TW200305414A - β 3 -Adrenergic receptor agonist salt, formulations, and uses thereof - Google Patents

β 3 -Adrenergic receptor agonist salt, formulations, and uses thereof Download PDF

Info

Publication number
TW200305414A
TW200305414A TW092104035A TW92104035A TW200305414A TW 200305414 A TW200305414 A TW 200305414A TW 092104035 A TW092104035 A TW 092104035A TW 92104035 A TW92104035 A TW 92104035A TW 200305414 A TW200305414 A TW 200305414A
Authority
TW
Taiwan
Prior art keywords
ethanol
monohydrate
salt
phenoxy
ethylamino
Prior art date
Application number
TW092104035A
Other languages
English (en)
Chinese (zh)
Inventor
Joseph Francis Krzyzaniak
Jennifer Anne Lafontaine
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of TW200305414A publication Critical patent/TW200305414A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW092104035A 2002-02-27 2003-02-26 β 3 -Adrenergic receptor agonist salt, formulations, and uses thereof TW200305414A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36024802P 2002-02-27 2002-02-27

Publications (1)

Publication Number Publication Date
TW200305414A true TW200305414A (en) 2003-11-01

Family

ID=27766205

Family Applications (1)

Application Number Title Priority Date Filing Date
TW092104035A TW200305414A (en) 2002-02-27 2003-02-26 β 3 -Adrenergic receptor agonist salt, formulations, and uses thereof

Country Status (8)

Country Link
AR (1) AR038603A1 (fr)
AU (1) AU2003248355A1 (fr)
GT (1) GT200300044A (fr)
PA (1) PA8567601A1 (fr)
PE (1) PE20030900A1 (fr)
TW (1) TW200305414A (fr)
UY (1) UY27678A1 (fr)
WO (1) WO2003072571A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9812709D0 (en) * 1998-06-13 1998-08-12 Glaxo Group Ltd Chemical compounds
CA2423792A1 (fr) * 2000-10-20 2002-04-25 Pfizer Products Inc. Ethanolamines alpha-aryle et utilisation de ces dernieres en tant qu'agonistes du recepteur adrenergique beta-3

Also Published As

Publication number Publication date
AR038603A1 (es) 2005-01-19
PA8567601A1 (es) 2003-12-10
PE20030900A1 (es) 2003-10-25
UY27678A1 (es) 2003-10-31
AU2003248355A1 (en) 2003-09-09
GT200300044A (es) 2003-09-22
WO2003072571A1 (fr) 2003-09-04

Similar Documents

Publication Publication Date Title
US5232946A (en) Phenylethanolamines, their use as pharmaceuticals and as performance enhancers in animals
CN1264381A (zh) 4－氨基吡咯并(3,2－d)嘧啶作为神经肽Y受体拮抗药
JPH1087615A (ja) β−アドレナリン作動性受容体
JPH11228447A (ja) 組み合わせ療法
US12060335B1 (en) 2-(benzo[d]oxazol-2-yl)-N′-(3,5-dichlorobenzoyloxy)acetimidamide as an antimicrobial compound
US11976051B1 (en) N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)-2-naphthimidamide as an antimicrobial compound
JPH11504648A (ja) β−アドレナリン作動性アゴニスト
US11897849B1 (en) N′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)-1-naphthimidamide as antimicrobial compound
US6689800B2 (en) β3-adrenergic receptor agonist crystal forms, processes for the production thereof, and uses thereof
TW200305414A (en) β 3 -Adrenergic receptor agonist salt, formulations, and uses thereof
US5026702A (en) Morpholines and morpholine-N-oxides and pharmaceutical compositions containing these compounds
US11932610B1 (en) 4-(5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)butanoic acid as an antimicrobial compound
US11932612B1 (en) 6-(5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)hexanoic acid as an antimicrobial compound
US12054464B1 (en) Methyl 4-((5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)methyl)benzoate as an antimicrobial compound
US12122770B1 (en) 2-(benzo[d]oxazol-2-yl)-n'-(nicotinoyloxy)acetimidamide as an antimicrobial compound
US11958816B1 (en) N′-({[(5-phenyl-1,3,4-oxadiazol-2-yl)sulfanyl]acetyl}oxy)benzenecarboximidamide as an antimicrobial compound
US11905280B1 (en) 2-(benzo[d]oxazol-2-yl)-N'-(picolinoyloxy)acetimidamide as an antimicrobial compound
US11905259B1 (en) 2-(benzo[d]oxazol-2-yl)-N′-(4-(dimethylamino)benzoyloxy)acetimidamide as an antimicrobial compound
US12090143B1 (en) 4-chloro-N′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide as an antimicrobial compound
US11970465B1 (en) Ethyl {[4-benzoyl-5-(3-fluorophenyl)-4H-1,2,4-triazol-3-yl]thio}acetate as an antimicrobial compound
US11912694B1 (en) 2-(benzo[d]oxazol-2-yl)-N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)acetimidamide as an antimicrobial compound
US11939305B1 (en) Ethyl 2-(5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)acetate as an antimicrobial compound
US11905263B1 (en) 4-nitro-N′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide as an antimicrobial compound
US11891366B1 (en) 4-methoxy-n′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide as an antimicrobial compound
US12006288B1 (en) 3-(4-chlorophenyl)-5-{[5-methyl-2-(propan-2-yl)phenoxy]methyl}-1,2,4-oxadiazole as an antitumor and antimicrobial compound